Search Results 8031-8040 of 28617 for oral
Unable to swallow and retain oral medication. Unable to comprehend or unwilling to sign the informed consent form (ICF). Any known contraindications to the ...
Patients randomized to GDC-0199+R will be given GDC-0199 daily (oral, target dose 400 mg) and will receive 6 cycles of rituximab infused intravenously (IV) ...
... Oral and throat cancer, Adenocarcinoma, Tongue base cancer, Oropharyngeal cancer. Show more areas of focus for Eric J. Moore, M.D.. Adyr A ...
... Oral and throat cancer, Adenocarcinoma, Laryngeal cancer, Carotid body tumor, Tongue base cancer, Mouth tumor, Salivary gland cancer, Parotid cancer ...
... Oral ulcerative condition, Facial volume loss, Vulvar disorder. Show more areas of focus for Alison J. Bruce, M.B., Ch.B. William ...
... oral board examinees in different practice settings. Int Urogynecol J. 2019 Jul; 30 (7):1153-1161 Epub 2018 Apr 13. View PubMed; Hassani DB, Mangel JM ...
Oral and Maxillofacial Surgery · Oropharynx Cancer Clinic in Minnesota · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Hematology/Oncology · Plastic ...
Drink more water or follow a doctor's recommendation to drink oral rehydration solutions. Other conditions that might require increased fluid intake include ...
ructive surgery, Oral surgery, Skin cancer excision, Microvascular reconstruction, Transoral laser microsurgery, Facial reconstruction, Parotid gland ...
The purpose of this study is to evaluate the safety, feasibility and acceptability of telehealth assessments for patients with GBM receiving oral chemotherapy.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Give by Dec. 31 to multiply your impact 3×.